Anteis S.A.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 8, 2027The maintenance fee for Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (US 10,434,040) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
- 1 fee due May 5, 2027The maintenance fee for Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (US 10,463,762) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (US 10,493,006) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
- 1 fee due Jul 28, 2027The maintenance fee for Peptides for skin rejuvenation and methods of using the same (US 10,543,195) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions (US 9,326,930) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,468,779 | Viscoelastic gel for dermatological use In force · From the USPTO record | In force | From the USPTO record | |
| US 8,052,990 | Biocompatible crosslinked gel In force · From the USPTO record | In force | From the USPTO record | |
| US 8,394,371 | Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US D702,835 | Needle retaining device In force · From the USPTO record | In force | From the USPTO record | |
| US 8,685,944 | Viscoelastic gel for dermatological use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,623,150 | Injectable hydrogel for the long-term supplementation of glycerol in the skin In force · From the USPTO record | In force | From the USPTO record | |
| US 8,455,465 | Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine In force · From the USPTO record | In force | From the USPTO record | |
| US 8,574,629 | Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume In force · From the USPTO record | In force | From the USPTO record | |
| US 9,326,930 | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 9,629,856 | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 20: 2 patents in force now held by others · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 no status recorded